CD274 and neoplasm: Using metagenomics, all three studies identified favorable relationships between specific types of colonic commensal bacteria with beneficial anti-tumor immune responses and clinical outcomes following initiation of PD-1/PD-L1-targeted immunotherapy in patients mostly with metastatic melanoma or urothelial cancer.